Literature DB >> 9089557

Sexuality, hormones and the menopausal transition.

L Dennerstein1, E C Dudley, J L Hopper, H Burger.   

Abstract

OBJECTIVES: To assess the validity and reliability of a sexuality questionnaire, and to assess the relationship of sexual functioning to age, menopausal status and hormone levels.
METHODS: Cross-sectional analysis of a population-based cohort of 201 women aged 48-58 years in the fourth year of a longitudinal study. Sexual functioning was measured by self-completed questionnaire. E2, FSH. Inhibin, total T and SHBG were sampled on cycle days 4-8 or after 3 months of amenorrhoea.
RESULTS: Internal consistency, as measured by Cronbach's alpha, was 0.71. Six factors were found on principal components factor analysis: (1) Feelings for Partner, (2) Sexual Responsivity, (3) Sexual Frequency, (4) Libido, (5) Partner Problems and (6) Vaginal Dryness/Dyspareunia. Sexual Responsivity decreased with age (beta = -0.060, P = 0.05), and Vaginal Dryness/Dyspareunia decreased with log E2 (beta = -0.181. P < 0.001). Testosterone was not associated with the aspects of female sexual functioning measured in this study.
CONCLUSIONS: This longitudinal study found that most aspects of female sexual functioning were not affected by age, menopausal functioning or hormone levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9089557     DOI: 10.1016/s0378-5122(96)01093-6

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  18 in total

Review 1.  Lower urinary tract disease: what are we trying to treat and in whom?

Authors:  Jeremy P W Heaton
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women.

Authors:  A M Fonseca; V R Bagnoli; S R L Penteado; J S Paixão; A L Cavalcanti; J A Pinotti
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

3.  Psychosexual health 5 years after hysterectomy: population-based comparison with endometrial ablation for dysfunctional uterine bleeding.

Authors:  Klim McPherson; Aleks Herbert; Andrew Judge; Aileen Clarke; Stephen Bridgman; Michael Maresh; Chris Overton
Journal:  Health Expect       Date:  2005-09       Impact factor: 3.377

4.  Dyspareunia is associated with decreased frequency of intercourse in the menopausal transition.

Authors:  Holly M Thomas; Cindy L Bryce; Roberta B Ness; Rachel Hess
Journal:  Menopause       Date:  2011-02       Impact factor: 2.953

5.  Dyspareunia in Puerto Rican middle-aged women.

Authors:  Yaniris R Avellanet; Ana Patricia Ortiz; José R Pando; Josefina Romaguera
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

6.  Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation.

Authors:  Nancy E Avis; Sarah Brockwell; John F Randolph; Shunhua Shen; Virginia S Cain; Marcia Ory; Gail A Greendale
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

Review 7.  Sildenafil citrate for female sexual arousal disorder: a future possibility?

Authors:  Corina Schoen; Gloria Bachmann
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

Review 8.  Dyspareunia in postmenopausal women: a critical review.

Authors:  A Kao; Y M Binik; A Kapuscinski; S Khalife
Journal:  Pain Res Manag       Date:  2008 May-Jun       Impact factor: 3.037

9.  Association of lifestyle and relationship factors with sexual functioning of women during midlife.

Authors:  Rachel Hess; Molly B Conroy; Roberta Ness; Cindy L Bryce; Stacey Dillon; Chung-Chou Ho Chang; Karen A Matthews
Journal:  J Sex Med       Date:  2009-05       Impact factor: 3.802

10.  Sexuality and breast cancer: prime time for young patients.

Authors:  Ana Catarina Pinto
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.